Back to search
Febrile Neutropenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Febrile Neutropenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Febrile Neutropenia trials you may qualify forUndergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monito…
The goal of this clinical trial is to learn if a personalized duration of antibiotic therapy, based on clinical stability, is as effective as a standard duratio…
Pre-neutropenic fever (PNF) (fever following chemotherapy but before developing low white cells) and neutropenic fever (NF) (fever in the setting of low white c…
This is a prospective observational study designed to observe and evaluate the safety and efficacy of mecapegfilgrastim in the treatment of moderate-to-severe m…
This single-arm, open-label clinical study evaluates the efficacy and safety of a standardized empirical anti-infective escalation protocol for patients with he…
Efbemalenograstim alfa for primary/secondary prevention in patients with solid tumors at high risk for febrile neutropenia (FN) or Intermediate risk of chemothe…
Chemotherapy-induced febrile neutropenia (CIFN) is a dangerous complication of many chemotherapy drugs, with current treatment with granulocyte colony-stimulati…
Febrile neutropenia (FN) is a common oncologic emergency in patients with hematologic malignancies, associated with high morbidity and mortality. Early identifi…